Keywords: Targeted cancer drugs, Fatal side effect risks, Nexavar, Sutent, Votrient

Three “targeted” cancer drugs slightly raise fatal side effects risk, says Dana-Faber Inst

Article | 08 February 2012

Print This

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in